Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Chinese Journal of Integrative Medicine

12-01-2024 | Original Article

Modified Sijunzi Granules Exhibit Hemostatic Effect by Activating Akt and Erk Signal Pathways via Regulating 5-HT and Its Receptors Levels

Authors: Jun Wang, Xue-ying Zhang, Yan-hong Kang, Yun Zhang, Xin-yi Chen, Jia-li Zhou, Dr. Wei Ma

Published in: Chinese Journal of Integrative Medicine

Login to get access
Metadata
Title
Modified Sijunzi Granules Exhibit Hemostatic Effect by Activating Akt and Erk Signal Pathways via Regulating 5-HT and Its Receptors Levels
Authors
Jun Wang
Xue-ying Zhang
Yan-hong Kang
Yun Zhang
Xin-yi Chen
Jia-li Zhou
Dr. Wei Ma
Publication date
12-01-2024
Publisher
Springer Nature Singapore
Published in
Chinese Journal of Integrative Medicine
Print ISSN: 1672-0415
Electronic ISSN: 1993-0402
DOI
https://doi.org/10.1007/s11655-023-3567-6